Swiss stocks - Factors to watch on October 2

Reuters10-02
Swiss stocks - Factors to watch on October 2

ZURICH/GDANSK, October 2 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday:

PHARMACEUTICALS

Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff relief, a major Swiss chemical and pharmaceutical industry association said on Wednesday. European and U.S. healthcare stocks surged on Wednesday.

COMPANY STATEMENTS

* Roche ROG.S says company commences tender offer for all shares of 89BioETNB.O

ANALYSTS' VIEWS

*BARRY CALLEBAUT AG BARN.S - Berenberg cuts to hold from buy; raises target price to CHF 1,200 from CHF 1,110

ECONOMY

Swiss CPI due at 06:30 GMT.

(Reporting by Zurich newsroom and Gdansk newsroom)

((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E

SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment